Meanwhile, miR-18b directly suppresses connective tissue growth factor (CTGF) expression in NPC which leads to NPC progression and poor prognosis due to the downregulation of CTGF [78]. The gene discussed is CCN2; the disease is nasopharyngeal carcinoma.